Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | RET | P07949 | 2/20 | 0.33 |
| ▸ | GRK5 | P34947 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 4/20 | 0.33 |
| ▸ | ITGA2 | P17301 | 4/20 | 0.33 |
| ▸ | PBRM1 | Q86U86 | 3/20 | 0.33 |
| ▸ | GUSB | P08236 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.32 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.32 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11300615 | 0.79 | BCHE (0.46) | HTT | |
| SCHEMBL8948577 | 0.73 | TTR (0.32) | TTRCES1GUSB | |
| Alcohol SCHEMBL8473894 | 0.63 | AHR (0.36) | AHRTSHRHTT | |
| SCHEMBL9780105 | 0.63 | TSHR (0.40) | TTRCES1AHRRETGRK5 | |
| SCHEMBL259173 | 0.63 | CES1 (0.36) | CES1AHRRETGRK5TYRO3 | |
| SCHEMBL259172 | 0.63 | CES1 (0.36) | CES1AHRRETGRK5TYRO3 | |
| SCHEMBL4260328 | 0.63 | SMARCA2 (0.37) | CES1PBRM1DAOHTTCACNG8 | |
| SCHEMBL2471569 | 0.62 | TSHR (0.57) | CES1RETGRK5TYRO3DYRK1B | |
| SCHEMBL8809006 | 0.62 | PBRM1 (0.36) | CES1RETGRK5TYRO3DYRK1B | |
| SCHEMBL4496746 | 0.61 | PBRM1 (0.39) | CES1PBRM1TSHRHTTGRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040199014-A1 | Method for producing 2-(hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives | BAYER CROPSCIENCE AG (DE) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199014-A1 | Method for producing 2-(hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives | HMOX2, AADAC, HNMT | TTR 2596/4885CES1 3113/4885AHR 759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.